The restructuring is only the latest round of layoffs to hit Arbutus after the company shed 40% of its staff and cut back on ...
Introduction How Serious is the Problem? Treatment Options Increasing Pegylation Increases Half-Life... References ...
Medpage Today on MSN3mon
RNA Interference Therapeutic Shows Promise for Chronic Hepatitis BOut of five medication regimens given for 48 weeks in the open-label Piranga study, combination xalnesiran plus pegylated ...
The combination of imdusiran and pegylated interferon alfa-2a (IFN) was generally safe and well-tolerated. The IM-PROVE II trial combined imdusiran with VTP-300, showing significant reductions in ...
The patient was on maintenance dialysis and was receiving pegylated interferon monotherapy for her chronic hepatitis C virus infection. Investigations. Physical examination, laboratory tests ...
BESREMi® (ropeginterferon alfa-2b) is a long-acting, mono-pegylated proline interferon (ATC L03AB15). It is administered once every 2 weeks initially, or up to every 4 weeks after stabilization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback